Weight Loss Injections in Nottingham: What the Trials and Guidance Actually Show

What the landmark trials actually found

The clinical case for injectable weight-loss treatment is built on two substantial bodies of evidence. The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity but without type 2 diabetes and tested tirzepatide over 72 weeks. At the highest dose, participants lost around 20–21% of their body weight on average. That's not a modest result. The STEP 1 trial ran a similar design for semaglutide 2.4mg over 68 weeks, finding roughly 15% average weight reduction against placebo. Both trials included lifestyle support alongside the medicine, which matters, the injections work best when paired with changes to diet and activity.

NICE reviewed this evidence carefully. Its appraisal of tirzepatide, published in December 2024 and updated in September 2025, recommends the medicine for eligible adults in England. Its earlier appraisal of semaglutide (Wegovy) set out a different access pathway via specialist services. You can read the full recommendation criteria on the NICE tirzepatide guidance page (TA1026). The evidence base is solid. The results in real-world practice vary, but the trials give a reliable benchmark.

One misconception worth clearing up gently: many people assume these medicines work by speeding up metabolism. They don't, primarily. They act on appetite-regulating receptors in the gut and brain, slowing gastric emptying and reducing hunger signals. Weight follows from eating less, the medicine changes what your body is asking for, not how fast it burns calories.

Who these injections are licensed for, and where Nottingham fits in

Living in Nottingham doesn't change the clinical criteria, but it does affect NHS access. On the NHS, tirzepatide is being rolled out in phases across England: the current cohort (from June 2025) covers adults with a BMI of 40 or above alongside four or more qualifying health conditions, including high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease or type 2 diabetes. A second cohort, with a BMI of 35–39.9, activated in June 2026. GP practices in Nottinghamshire may participate in prescribing under the 2026/27 GP contract, though participation varies by practice and NHS waiting lists remain a reality for many.

Private prescribing follows the licensed criteria directly: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as hypertension, prediabetes or high cholesterol. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. For people who don't meet the NHS phased criteria or would rather not wait, a regulated online pharmacy is the practical alternative. If you want to understand which of the 3 weight loss injections currently available in the UK might suit your situation before deciding, that page sets out how they compare. If you want to understand the broader treatment landscape before deciding, our overview of injectable weight-loss treatment in the UK sets out the options clearly.

BMI alone doesn't determine suitability. A prescriber looks at your full health picture, current medicines, medical history, and any conditions that might affect how you respond to treatment or tolerate the dose escalation schedule. That assessment is the point.

Side effects, safety, and what to watch for

The NHS medicines page for tirzepatide on NHS.uk lists the common side effects clearly: nausea, vomiting, diarrhoea, constipation, indigestion, and fatigue are the most frequently reported. For most people, these are most noticeable in the first few weeks or after a dose increase, then settle. Keeping well hydrated and eating smaller, lower-fat meals during the adjustment period tends to help.

There are rarer but more serious signals to be aware of. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines, highlighting acute pancreatitis as an infrequent but potentially serious risk. The symptom to act on is severe, persistent stomach pain that radiates to the back, with or without vomiting, that warrants urgent medical attention, not a wait-and-see. You can also report any suspected side effects directly through the MHRA's Yellow Card scheme.

On buying safely: the MHRA has warned repeatedly about fake weight-loss pens sold through social media and unregistered websites. Some of those counterfeits have contained insulin rather than the stated medicine, a genuinely dangerous substitution. Any pharmacy dispensing these medicines legally in the UK must be registered with the General Pharmaceutical Council. You can verify a pharmacy's registration at any point on the GPhC register. If a seller offers tirzepatide or semaglutide without requiring a valid prescription from a registered prescriber, that is a red flag worth taking seriously. Guidance on buying weight loss injections safely covers the checks to run before purchasing anywhere.

How accessing treatment through a regulated online pharmacy works

Because weight loss injections are prescription-only, the process is the same whether you're in Nottingham, Birmingham or anywhere else in England. A regulated online pharmacy conducts a clinical consultation, a qualified prescriber reviews your answers, and the prescription is only issued if you're clinically suitable. At nume, that review is carried out by a GPhC-registered Independent Prescriber, a real clinician, not an automated system. Photo-ID and live weight verification are part of the process, and your GP is notified in line with GPhC guidance.

Once approved, treatment is dispatched the same day for orders placed before 12pm Monday to Friday, and delivered free the next working day by DPD in plain, unbranded packaging. There's no subscription and no auto-renewal. Every repeat order goes through clinical review again, the same standard, every time. You can see what's involved in the full process on our treatment and consultation page, or read more about how our clinical team approaches prescribing decisions on the clinical team page.

For context on what these medicines typically cost through a private pharmacy, our weight-loss treatment overview explains the pricing structure honestly. Treatment pricing has shifted since Eli Lilly raised its UK list price in September 2025, and any legitimate quote should include the consultation, prescription and delivery rather than just the pen price. If you're based in the West Midlands and exploring your options locally, you can find out more about weight loss injections in Birmingham on our dedicated area page. A sharps bin for safe disposal is worth arranging before your first pen arrives, a 1-litre sharps container is the standard size for home use.

If you've been through the process and feel your results have stalled, there's guidance on what to do when injections don't seem to be working, it's a question our prescribers hear regularly, and there are usually clear clinical reasons worth exploring. When you're ready to take the next step, if you'd like a full breakdown of how a weight loss injection works in practice before your consultation, that page covers the treatment in detail, and a prescriber will review your situation the same day.